Results 71 to 80 of about 673 (120)

Factors Associated with Survival From Xp11.2 Translocation Renal Cell Carcinoma Diagnosis-A Systematic Review and Pooled Analysis. [PDF]

Pathol Oncol Res, 2021
Wu Y, Chen S, Zhang M, Liu K, Jing J, Pan K, Zhang L, Xu B, Lu X, Chen M.   +9 more
europepmc   +1 more source

A radiomics-based interpretable model to distinguish Xp11.2/TFE3 translocation renal cell carcinoma and common types of renal cell carcinoma on CT images

Cancer Treatment and Research Communications
Background: TFE3-RCC is rare, hard to distinguish from common RCC on CT, posing preoperative diagnostic challenges for clinicians.This two-center study aimed to develop interpretable machine learning models using radiomics to differentiate Xp11.2/TFE3 ...
Yi Liu, Qi Shen, Kexin Wang, Yaofeng Zhang, Jiangtao Liu, Jianxing Qiu, Xiaoying Wang   +6 more
doaj   +1 more source

The association between metabolic syndrome and renal cell carcinoma

Zhongguo aizheng zazhi, 2016
Background and purpose: The association between metabolic syndrome (MS) and renal cell carcinoma (RCC) is still unknown. The aim of this study was to elucidate how MS correlates with the prevalence and malignancy of RCC.
李　慧, 王弘恺, 顾伟杰
doaj  

CT/MRI features of renal carcinomas associated with Xp11.2 translocation/TFE3 gene fusions

肿瘤影像学, 2018
Objective: To investigate the imaging features of renal carcinomas associated with Xp11.2 translocation/TFE3 gene fusions (Xp11.2/TFE RCC). Methods: The imaging data of 14 patients with Xp11.2/TFE RCC confirmed by operation and biopsy were analyzed ...
WANG Lu, XU Pengju, ZHU Mingming
doaj  

Nephron-Sparing Surgery for Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical T1 Stage: A Multicenter Study in China. [PDF]

Ann Surg Oncol, 2021
Liu N, Qu F, Shi Q, Zhuang W, Ma W, Yang Z, Sun J, Xu W, Zhang L, Jia R, Xu L, Zhao X, Li X, Zhang G, Guo H, Li D, Gan W.   +16 more
europepmc   +1 more source

Metastatic adult Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion in complete remission. [PDF]

Proc (Bayl Univ Med Cent), 2020
Manogna D, Tenneti D, Kramer Z.
europepmc   +1 more source

Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion in the elderly: case report and literature review. [PDF]

Int Cancer Conf J, 2020
Masago T, Kobayakawa S, Ohtani Y, Taniguchi K, Naka T, Kuroda N, Takahashi C, Isoyama T, Sejima T.   +8 more
europepmc   +1 more source

An immunohistochemical diagnostic panel for Xp11.2 translocation renal cell carcinoma: A diagnostic accuracy study. [PDF]

Medicine (Baltimore)
Wei M, Pan B, Yang W, Xu W, Dong J.
europepmc   +1 more source

A novel urinary biomarker of Xp11.2 translocation renal cell carcinoma

European Urology Open Science, 2020
R. Kurahashi, T. Kadomatsu, Y. Oike, T. Kamba   +3 more
doaj   +1 more source

TFE3 fusion proteins promoted the progression of Xp11.2 translocation renal cell carcinoma through post-translational modification of PDL1 by upregulating CCND1/Cyclin D1. [PDF]

Cell Oncol (Dordr)
Lu Y, Chen Y, Pan X, Ma W, Liu N, Yang L, Dong X, Guo H, Li D, Gan W.   +9 more
europepmc   +1 more source